Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 11 results:
Συντάκτης Τίτλος [ Τύπος![(Asc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-asc.png)
Φίλτρα: Συντάκτης is Briasoulis, Evangelos [Clear All Filters]
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation..
Oncology. 76(4), 275-85.
(2009). Revisiting bleomycin from pathophysiology to safe clinical use..
Crit Rev Oncol Hematol. 87(1), 90-100.
(2013). Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival..
Ann Hematol. 97(9), 1671-1682.
(2018).
(2010). Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis..
J Exp Clin Cancer Res. 29, 68.
(2010). Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial..
Breast Cancer Res Treat. 132(2), 609-19.
(2012). Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study..
Anticancer Drugs. 21(8), 785-9.
(2010). Microcystin LR Shows Cytotoxic Activity Against Pancreatic Cancer Cells Expressing the Membrane OATP1B1 and OATP1B3 Transporters..
Anticancer Res. 35(11), 5857-65.
(2015). Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer..
Clin Cancer Res. 15(20), 6454-61.
(2009).
(2013).
(2014).